Key facts
- It has raised $25.0M; the latest was Early Stage VC ($3.0M) in Mar 2025.
- Notable investors include Antler, Service Provider Capital, University of California, Gates Foundation, ANIMO Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Synvect
- ·The full record, as it builds
Funding rounds
No funding rounds for Synvect are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synvect
Developer of mosquito control technology intended to utilize clustered regularly interspaced short palindromic repeats gene knockouts to sterilize mosquito eggs. The company specializes in mosquito control services and leading to the suppression of harmful mosquito populations, enabling researchers to be dedicated to eradicating mosquito-borne illnesses through affordable, user-friendly biological services.
- Sector
- Business Products and Services (B2B)
- HQ
- San Diego, CA, United States
- Founded
- 2022
- Employees
- 7
- Website
- synvect.com/
- Ownership
- Privately Held (backing)
Synvect doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synvect shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synvect in its N-PORT filings yet. We sweep new filings monthly.